Human skin endothelial cells can express all 10 TLR genes and respond to respective ligands

被引:87
作者
Fitzner, Nicole [1 ]
Clauberg, Sigrid [1 ]
Essmann, Frank [2 ]
Liebmann, Joerg [1 ]
Kolb-Bachofen, Victoria [1 ]
机构
[1] Univ Dusseldorf, Res Grp Immunobiol, Inst Mol Med, D-40001 Dusseldorf, Germany
[2] Univ Dusseldorf, Inst Mol Med, D-40001 Dusseldorf, Germany
关键词
D O I
10.1128/CVI.00257-07
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Breakdown of the skin barrier requires the recognition of and rapid responses to invading pathogens. Since wounding usually also affects endothelial intactness, the expression of receptors of the Toll-like family involved in pathogen recognition in human skin vessel endothelia was examined. We found that human skin- derived microvascular endothelial cells can express all 10 Toll-like receptors (TLRs) currently known and will respond to respective ligands. Using immortalized skin- derived (HMEC-1) and primary dermal endothelial cells (HDMEC), we screened for TLR expression by real-time PCR. Endothelial cells express 7 (for HDMEC) and 8 (for HMEC-1) of the 10 known human TLRs under resting conditions but can express all 10 receptors in proinflammatory conditions. To provide evidence of TLR functionality, endothelial cells were challenged with TLR ligands, and after the TLR downstream signaling, MyD88 recruitment as well as early (interleukin-8 [IL-8] release) and late immune markers (inducible nitric oxide synthase mRNA expression) were monitored. Surprisingly, the responses observed were not uniform but were highly specific depending on the respective TLR ligand. For instance, lipopolysaccharides highly increased IL-8 release, but CpG DNA induced significant suppression. Additionally, TLR-specific responses were found to differ between resting and activated endothelial cells. These results show that human skin- derived endothelial cells can function as an important part of the innate immune response, can actively sense pathogen-associated molecular patterns, and can mount an increased or reduced inflammatory signal upon exposure to any of the currently known TLR ligands. Moreover, we also show here that proinflammatory conditions may affect TLR expression in a specific and nonuniform pattern.
引用
收藏
页码:138 / 146
页数:9
相关论文
共 27 条
[1]   Poly-guanosine strings improve cellular uptake and stimulatory activity of phosphodiester CpG oligonucleotides in human leukocytes [J].
Bartz, H ;
Mendoza, Y ;
Gebker, M ;
Fischborn, T ;
Heeg, K ;
Dalpke, A .
VACCINE, 2004, 23 (02) :148-155
[2]   The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells [J].
Bourke, E ;
Bosisio, D ;
Golay, J ;
Polentarutti, N ;
Mantovani, A .
BLOOD, 2003, 102 (03) :956-963
[3]   Endothelial chemokines in autoimmune disease [J].
Christopherson, KW ;
Hromas, RA .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (02) :145-154
[4]   The Toll-like receptors and their role in septic shock [J].
Cristofaro, P ;
Opal, SM .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2003, 7 (05) :603-612
[5]   Expression of toll-like receptors in human atherosclerotic lesions - A possible pathway for plaque activation [J].
Edfeldt, K ;
Swedenborg, J ;
Hansson, GK ;
Yan, ZQ .
CIRCULATION, 2002, 105 (10) :1158-1161
[6]   Human immunodeficiency virus type 1 protease inhibitors block toll-like receptor 2 (TLR2)- and TLR4-induced NF-κB activation [J].
Equils, O ;
Shapiro, A ;
Madak, Z ;
Liu, CR ;
Lu, DN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (10) :3905-3911
[7]   Bacterial lipopolysaccharide activates NF-κB through Toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells -: Differential expression of TLR-4 and TLR-2 in endothelial cells [J].
Faure, E ;
Equils, O ;
Sieling, PA ;
Thomas, L ;
Zhang, FX ;
Kirschning, CJ ;
Polentarutti, N ;
Muzio, M ;
Arditi, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (15) :11058-11063
[8]   Bacterial lipopolysaccharide and IFN-γ induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells:: Role of NF-κB activation [J].
Faure, E ;
Thomas, L ;
Xu, H ;
Medvedev, AE ;
Equils, O ;
Arditi, M .
JOURNAL OF IMMUNOLOGY, 2001, 166 (03) :2018-2024
[9]  
Fitzner N, 2006, EUR J CELL BIOL, V85, P114
[10]  
FITZNER N, 2007, THESIS U DUESSELDORF